Filing Details
- Accession Number:
- 0001209191-17-057667
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-20 17:23:29
- Reporting Period:
- 2017-10-18
- Accepted Time:
- 2017-10-20 17:23:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 876378 | Transenterix Inc. | TRXC | Surgical & Medical Instruments & Apparatus (3841) | 112962080 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1584367 | Todd Pope | C/O Transenterix, Inc. 635 Davis Drive, Suite 300 Morrisville NC 27560 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-10-18 | 95,335 | $0.35 | 462,644 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-10-18 | 287,356 | $0.35 | 750,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-10-18 | 600,000 | $3.68 | 150,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2017-10-18 | 95,335 | $0.00 | 95,335 | $0.35 |
| Common Stock | Stock Option | Disposition | 2017-10-18 | 287,356 | $0.00 | 287,356 | $0.35 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-12-14 | 2019-12-14 | No | 4 | M | Direct |
| 138,555 | 2015-02-02 | 2022-04-12 | No | 4 | M | Direct |
Footnotes
- The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended.
- The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.46 to $4.23 inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Billionaire Hedge Funds
